Found 6 matching trials
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
PHASE1This is a phase 1/2, multicenter, dose-finding and dose expansion study of ...
Location
Institut Jules Bordet
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
PHASE2TEDOPAM is a randomized (1.1.1) non-comparative phase II study. This study ...
Status
Active Not Recruiting
Location
Clinique de l'Europe
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure
PHASE3The aim of this clinical trial was to determine if the therapeutic cancer v...
Location
East Valley Hematology and Oncology medical Group
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
PHASE3Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive ...
Location
Clinical Research Advisors, LLC
A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.
PHASE2This is a phase II randomized study investigating whether a combination mai...
Location
Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
PHASE2The proposed study is an international randomized phase II, multicenter, op...
Status
Active Not Recruiting